KLI

안질환 환자의 유리체액과 혈청에 존재하는 아데노부속바이러스 특이적 중화항체 분석

Metadata Downloads
Abstract
Purpose : We determine the prevalence of neutralizing antibodies (NAbs) to adeno-associated virus (AAV) in the vitreous humor and serum of patients with vitreoretinal diseases and investigate the relationship between NAb titers in the vitreous humor and serum.
Methods : We analyzed NAbs to AAV serotypes 2, 5, 8, and 9 via in vitro neutralization in the vitreous humor and serum from 32 patients requiring vitrectomy for vitreoretinal diseases. The blood–retinal barrier (BRB) was evaluated for integrity based on preoperative examinations, with vitreous hemorrhage (VH) on funduscopy or dye leakage on fluorescein angiography observed indicating disruption.
Results : NAb levels were much lower in the vitreous humor than in the serum regardless of serotype. Patients with VH had higher levels of NAbs in the vitreous humor than those without VH. The NAb ratio (ratio between NAb titers in the serum and vitreous humor) was much lower in patients with epiretinal membrane with than in those without leakage. A significantly lower NAb ratio was noticed in patients with than in those without BRB disruptions.
Conclusions : The NAb ratio between levels in serum and vitreous humor varies according to the condition of the BRB. Therefore, BRB integrity should be examined when planning retinal gene therapy. This study provides substantial basis for retinal gene therapy using AAVs and how maintenance of BRB integrity in target diseases should be considered.
Author(s)
강임경
Issued Date
2019
Awarded Date
2019-08
Type
Dissertation
URI
https://oak.ulsan.ac.kr/handle/2021.oak/6927
http://ulsan.dcollection.net/common/orgView/200000218567
Affiliation
울산대학교
Department
일반대학원 의학과의과학전공
Advisor
이희란
Degree
Master
Publisher
울산대학교 일반대학원 의학과의과학전공
Language
eng
Rights
울산대학교 논문은 저작권에 의해 보호받습니다.
Appears in Collections:
Medical Science > 1. Theses (Master)
Medical Engineering > 1. Theses(Master)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.